Valvular heart disease is an important source of cardiovascular morbidity and mortality.
Current prosthetic valve replacement options, such as bioprosthetic and mechanical heart …

Congenital heart diseases (CHDs) frequently impact the right ventricular outflow tract,
resulting in a significant incidence of pulmonary valve replacement in the pediatric …

Abstract Aims Bioprosthetic heart valves (BHVs), made from glutaraldehyde-fixed heterograft
materials, are subject to more rapid structural valve degeneration (SVD) in paediatric and …

Heart valves have extraordinary fatigue resistance which beat≈ 3 billion times in a lifetime.
Bioprosthetic heart valves (BHVs) made from fixed heteroplasm that are incrementally used …

With the aging of the population in worldwide, valvular heart disease has become one of the
most prominent life-threatening diseases in human health, and heart valve replacement …

Transcatheter aortic valve replacement (TAVR) has the advantages of less trauma and faster
postoperative recovery, which has brought the possibility to the elderly patient with valvular …

Valvular heart disease (VHD) has become a burden and a growing public health problem in
humans, causing significant morbidity and mortality worldwide. An increasing number of …

Valvular pathologies that induce deterioration in the aortic valve are a common cause of
heart disease among aging populations. Although there are numerous available …

Over the past few years, transcatheter aortic valve implantation (TAVI) imposed itself as the
first-choice therapy for symptomatic aortic stenosis (AS) in elderly patients at surgical risk …

Bioprosthetic heart valves (BHV) fabricated from glutaraldehyde-fixed heterograft tissue,
such as bovine pericardium (BP), are widely used for treating heart valve disease, a group of …